CME Group CEO Terry Duffy to step down, CFO Lynne Fitzpatrick to take the reins on March 1

1 hour ago 7

CME Group, the derivatives exchange behemoth with a market cap exceeding $95 billion, is getting a new boss. Terry Duffy, who has been the face of CME for the better part of two decades, will hand the CEO title to current President and CFO Lynne Fitzpatrick effective March 1, 2027.

Duffy isn’t exactly cleaning out his desk. He’ll transition to the role of Executive Chairman, keeping a seat at the table while Fitzpatrick takes the operational wheel.

A 46-year run and the empire Duffy built

Terry Duffy first walked through CME’s doors in 1980. He became Chairman in 2002 and added the CEO title in 2016. In the years between, he orchestrated a series of acquisitions that turned CME from a major exchange into the dominant one.

The purchases of CBOT, NYMEX, and NEX stitched together an empire spanning interest rates, energy, metals, and foreign exchange. A partnership with Google Cloud modernized the exchange’s technology infrastructure. And under Duffy’s watch, CME pushed aggressively into electronic trading.

CME Group achieved an average daily trading volume of 28.1 million contracts in 2025. For crypto markets specifically, Duffy’s legacy includes launching Bitcoin futures in December 2017 and Ether futures later on, giving institutional players their first regulated on-ramp to crypto exposure without touching the underlying assets.

Who is Lynne Fitzpatrick?

Fitzpatrick joined the company in 2006 and worked her way through the financial side of the operation, serving as Deputy CFO and Treasurer before being elevated to President and CFO in November 2024.

Fitzpatrick will also join CME Group’s board of directors as part of the transition.

What this means for crypto derivatives

Duffy has been publicly vocal about his concerns regarding perpetual futures products, the leveraged contracts that dominate offshore crypto exchanges and have recently gained CFTC approval for US-regulated platforms. His critique has centered on risk management, essentially arguing that these products introduce systemic risks that regulators and exchanges need to think carefully about.

Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our Editorial Policy.

Read Entire Article